Prothena | PRTA - Aset Lancar

Harga Saham
9.61
Perubahan Harian
-0.25 -2.54%
Bulanan
15.09%
Tahunan
-35.72%
Q1 Perkiraan
8.41




Aset Lancar Perubahan Tanggal
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Akebia Therapeutics USD 252.96M 5.38M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Exelixis USD 1.44B 41.03M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Incyte USD 5.02B 746.01M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Prothena USD 339.97M 45.51M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09